Azienda Socio Sanitaria Territoriale di Monza (Presidio San Gerardo)

Monza, Milano 20900

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Chronic Myeloid Leukemia (for Part B and C), Healthy (For Part A)

Studies at this site

• Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies — Stopped early
• DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02] — Completed
• Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04] — Running, not enrolling